AGP Picks
View all

French Guiana Wellness Network
Provided by AGP

French Guiana Wellness Network: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Guiana Wellness Network.

April 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30

May 2026

Mo Tu We Th Fr Sa Su
1 2 3
4 5 6 7 8 9 10
11 12 13 14 15 16 17
18 19 20 21 22 23 24
25 26 27 28 29 30 31

June 2026

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30

Press releases published on May 18, 2026

Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026
May 18, 2026

Alignment Healthcare to Present at the Goldman Sachs 47th Annual Global Healthcare Conference 2026

Indeterminate GlobeNewswire
SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System
May 18, 2026

SpyGlass Pharma Announces New Add-on Category III CPT Code for Its Innovative BIM-IOL System

Indeterminate GlobeNewswire
Reviva to Participate in Fireside Chat at A.G.P.’s Annual Healthcare Company Showcase
May 18, 2026

Reviva to Participate in Fireside Chat at A.G.P.’s Annual Healthcare Company Showcase

Indeterminate GlobeNewswire
BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease
May 18, 2026

BioVie Announces Completion of Phase 2 SUNRISE-PD Trial in Early-Stage Parkinson’s Disease

Indeterminate GlobeNewswire
Syneos Health Wins “Best Mobile App for Patient Engagement” in 2026 MedTech Breakthrough Awards
May 18, 2026

Syneos Health Wins “Best Mobile App for Patient Engagement” in 2026 MedTech Breakthrough Awards

Indeterminate GlobeNewswire
Kyverna Therapeutics Names Greg Martini as Chief Financial Officer
May 18, 2026

Kyverna Therapeutics Names Greg Martini as Chief Financial Officer

Indeterminate GlobeNewswire
Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies
May 18, 2026

Daré Bioscience Initiates Phase 2 Study of DARE-HPV, a Novel Pharmacologic Treatment for Persistent High-Risk HPV Infection with No FDA-Approved Therapies

Indeterminate GlobeNewswire
Provectus Biopharmaceuticals Reports Oral PV-10 Anti-Tumor Activity in Preclinical Bladder Cancer Study; Long-Term Survivors Show Absence of Gross Bladder Tumor at Study End
May 18, 2026

Provectus Biopharmaceuticals Reports Oral PV-10 Anti-Tumor Activity in Preclinical Bladder Cancer Study; Long-Term Survivors Show Absence of Gross Bladder Tumor at Study End

Indeterminate GlobeNewswire
Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026
May 18, 2026

Protara Therapeutics to Host Virtual Investor Webinar to Discuss TARA-002 for Lymphatic Malformations on Tuesday, May 19, 2026

Indeterminate GlobeNewswire
Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer
May 18, 2026

Route 92 Medical Announces Appointment of Raj Denhoy as Chief Financial Officer

Indeterminate GlobeNewswire
CATHETER PRECISION REPORTS 200% REVENUE GROWTH AND COMPLETES TRANSFORMATIVE FLYTE ACQUISITION
May 18, 2026

CATHETER PRECISION REPORTS 200% REVENUE GROWTH AND COMPLETES TRANSFORMATIVE FLYTE ACQUISITION

Indeterminate GlobeNewswire
Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa
May 18, 2026

Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEK® for the Treatment of Dystrophic Epidermolysis Bullosa

Indeterminate GlobeNewswire
Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis
May 18, 2026

Enlivex Announces Dosing Of First Patient In The United States As Part Of Its Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire
Novastra Therapeutics Appoints Chief Financial Officer as Company Advances Lead Candidate Toward Global Clinical Development
May 18, 2026

Novastra Therapeutics Appoints Chief Financial Officer as Company Advances Lead Candidate Toward Global Clinical Development

Indeterminate GlobeNewswire
Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models
May 18, 2026

Alaunos Reports Preclinical ALN1003 Data Showing Effects on Insulin-Resistance-Related Biomarkers and Liver Histology in Diet-Induced Obesity Models

Indeterminate GlobeNewswire
BrainsWay Announces Minority-Stake Investment in Hopemark Health
May 18, 2026

BrainsWay Announces Minority-Stake Investment in Hopemark Health

Indeterminate GlobeNewswire
Zenflow Presents the BREEZE™ Pivotal Clinical Trial at the American Urological Association Annual Meeting
May 18, 2026

Zenflow Presents the BREEZE™ Pivotal Clinical Trial at the American Urological Association Annual Meeting

Indeterminate GlobeNewswire
CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates
May 18, 2026

CervoMed Reports First Quarter 2026 Financial Results and Provides Corporate Updates

Indeterminate GlobeNewswire
NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation
May 18, 2026

NYU Langone Issues $580,000 Purchase Order for Inspira's FDA-Cleared ART100 Following Multi-Patient Hospital Evaluation

Indeterminate GlobeNewswire
NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates
May 18, 2026

NervGen Reports First Quarter 2026 Financial Results and Provides Business Updates

Indeterminate GlobeNewswire
Show More

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

French Guiana Wellness Network

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.